Am I right in thinking that the difference between our recent submission and the failed one before that, is that this time, we have an ex FDA employee, as one of our Board of Directors, proof reading and overseeing it, and thus agreeing with the contents of the submission only because he is satisfied that it now covers all requirements and therefore will be approved.
How does he view his role with Mesoblast..................
" Well, as a member of the board of directors of any company, I help provide direction to the company in strategic matters, as well as obviously oversight of what the CEO is doing."
I am referring of course to Philip Krause MD and I think his role with MSB is currently having a large effect on the SP.
Our submission Imo will most certainly be approved
Am I right in thinking that the difference between our recent...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |